NEW YORK (360Dx) – Novogene said that its next-generation sequencing medical lab in Tianjin, China, has received accreditation from the College of American Pathologists enabling it to provide clinical sequencing services to customers worldwide.

The firm noted that it recently launched the first NGS tumor gene-detection kit cleared by the China Food and Drug Administration.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.